Tasos Gogakos

2.5k citations
16 papers · 1.1k indexed · h-index 11

Tasos Gogakos

15 papers receiving 1.1k citations

Peers

Tasos Gogakos
Comparison fields: 5 of 82
  • Cancer Research 204
  • Immunology 268
  • Molecular Biology 776
  • Infectious Diseases 190
  • Internal Medicine 25
Replace Janice M. Staber with:
Janice M. Staber United States
Lisa G. van den Hengel Netherlands
Kathleen Pestal United States
Ruyuan Zhou China
Soujuan Wang United States
Hsin‐Pai Li Taiwan
Monique W. Bruinsma United States
Sharissa L. Latham Australia
Kousuke Tanimoto Japan
Janet L. Wee Australia
Tasos Gogakos relative to Janice M. Staber United States Janice M. Staber's profile →
Citations per field
00.5×7.6×
Janice M. Staber · 1×
Citations per year

Countries citing papers authored by Tasos Gogakos

Since Specialization
Citations

This map shows the geographic impact of Tasos Gogakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tasos Gogakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tasos Gogakos more than expected).

Fields of papers citing papers by Tasos Gogakos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tasos Gogakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tasos Gogakos. The network helps show where Tasos Gogakos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tasos Gogakos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tasos Gogakos Line = papers co-authored together Tasos Gogakos links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20235
2 20226
3 202129
4 202040
5 20200
6 202020
7 202010
8 20205
9 202063
10 201726
11 2017261
12 2017162
13 2017145
14 2014185
15 201376
16 201024

About Tasos Gogakos

Tasos Gogakos is a scholar working on Infectious Diseases, Cancer Research, Molecular Biology, Oncology and Immunology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (5 papers), RNA Research and Splicing (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers), SARS-CoV-2 detection and testing (2 papers), interferon and immune responses (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Cancer Research (204 citations), Immunology (268 citations), Molecular Biology (776 citations), Infectious Diseases (190 citations) and Internal Medicine (25 citations). Tasos Gogakos has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Thomas Tuschl, Cindy Meyer, Aitor Garzia, Miguel Brown, Pavel Morozov, Dinshaw J. Patel, Markus Hafner, Manuel Ascano, Jessica Vincent and Jumpei Aida. Their work appears in journals such as Nature Communications, Cell Reports, Nucleic Acids Research, Journal of Clinical Microbiology and Therapeutic Advances in Medical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026